A cute myocardial infarction (MI) occurs in >750 000 patients in the United States each year and is primarily caused by obstructive coronary artery disease (CAD). MI with nonobstructive coronary arteries (MINOCA), defined as <50% diameter stenosis in all major epicardial arteries, 1 occurs in ≤15% of acute MIs and is more common in women.
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Figure. Whole-blood transcriptome profiling identifies women with myocardial infarction with nonobstructive coronary artery disease (MINOCA).
Whole blood was collected into PAXgene Blood RNA tubes, RNA isolated and analyzed by RNA sequencing (Illumina HiSeq4000 Sequencing). Participants were clustered in hierarchical condition trees with each row representing a single gene and each column an individual subject. Color scale indicates normalized expression values, and colored bars indicate the individual's clinical classification. A, Transcript intensity for the top 1000 differentially expressed transcripts between MINOCA (n=11) and control (Ctrl) participants (n=9). B, Transcript intensity for the top 1000 differentially expressed transcripts between MINOCA (n=11) and myocardial infarction (MI)-coronary artery disease (CAD) participants (n=12). C and D, Volcano plots of differentially expressed genes in whole blood from MINOCA vs Ctrl, and MINOCA vs MI-CAD patients. The y axis corresponds to the P (−log 10 ), and the x axis displays the log(2-fold) change. The red dots represent the significantly differentially expressed transcripts (P<0.05). E, Modular analysis approach. Gene expression levels were compared between MINOCA and MI-CAD or Ctrl subjects on a module-by-module basis. Modules correspond to previously identified coregulated gene clusters that were assigned biological functions by unbiased literature profiling 4 (see legend grid below). Overabundance of transcripts in a module is depicted in red and underabundance in blue. The intensity of the dot corresponds to the percentage of genes in the respective module that are significantly (P<0.05) differentially expressed between groups. F, Canonical pathway analysis of significantly differentially regulated transcripts (P<0.05) in MINOCA vs Ctrl and MINOCA vs MI-CAD patients, and subsequent comparison of pathways identified. The significance of the association between transcript expression and a canonical pathway was measured by Fisher exact test, −log(P). ER (estrogen receptor) signaling was identified as the top common canonical pathway differentially expressed in both comparisons (MINOCA vs Ctrl, −log[P] 4.5; MINOCA vs MI-CAD, −log[P] 3. Three hundred and fifty common transcripts were differentially expressed between MINOCA versus controls and MINOCA versus MI-CAD subjects.
Modular gene expression analysis was performed to identify enriched cell types or pathways and found that participants with MINOCA had a reduced number of transcripts from genes associated with protein phosphatases and PI3K (phosphoinositide 3-kinase) family members (Figure [E] ; M3.4) versus controls. Transcripts associated with cytotoxic T cells were overrepresented in participants with MINOCA versus MI-CAD (Figure [E] ; M2.1).
To identify functional canonical pathway(s) unique to MINOCA, we performed ingenuity pathway analysis of the transcripts differentially regulated between MIN-OCA versus controls, MINOCA versus MI-CAD, and a subsequent comparison analysis. ER (estrogen receptor) signaling was identified as the top common canonical pathway differentially expressed in both comparisons, followed by mammalian target of rapamycin and eIF2 (eukaryotic initiation factor 2) signaling ( Figure [F] ).
The identification of estrogen signaling as the most significantly differentially regulated pathway in women with MINOCA versus MI-CAD and controls is a novel finding and might be relevant to understanding mechanisms of MINOCA. Estrogens have multiple beneficial effects on the heart and arterial wall, including vasodilation, inhibition of inflammation, antioxidant effects, and endothelial/cardiac cell survival after injury. 5 Additionally, enrichment in inflammatory cytotoxic T-cell transcripts and eIF2 signaling highlights a distinct mechanistic inflammatory pathway in MINOCA versus MI-CAD and controls.
Binding of estrogen to 1 of 3 receptors, ERα, ERβ, or GPER (G-protein-coupled ER), mediates its effect. ERα and ERβ function as ligand-activated transcription factors mediating effects in hormonally regulated tissues, whereas GPER is as a major mediator of estrogen's rapid cellular effects throughout the body. Our study found GPER to be the most abundant ER transcript in whole blood cells. GPER expression was reduced in participants with MINOCA compared with both MI-CAD and controls (Figure [G] ). Additionally, participants with MIN-OCA had decreased transcript expression of estrogen signaling-related genes (GRIP1, MED13, MED13L, and SOS2), estrogen-regulated genes (cFOS), and reduced expression of Mitogen-Activated Protein Kinase 1-a pathway that is rapidly activated after estrogen-GPER.
Our data indicate that women with MINOCA have a unique whole-blood transcriptional profile compared with patients with MI-CAD or women referred for invasive coronary angiography without obstructive CAD. We hypothesize these differences are mediated, in part, by estrogen signaling. Consistently, alterations to PI3K and mammalian target of rapamycin signalingestablished estrogen-regulated pathways-were demonstrated in women with MINOCA. Together, these results demonstrate the potential of mRNAs to provide further insight into the molecular mechanisms leading to the development of MINOCA with the potential to identify future therapeutic targets.
The data that support the findings of this study are available from the corresponding author on reasonable request. 
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